NCT01609283 A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1
NCT01592084 Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis Status COMPLETED Phase N/A
NCT01583088 Early Stage Amyotrophic Lateral Sclerosis Phrenic Stimulation Status TERMINATED Phase PHASE3
NCT01569958 Transcranial Direct Current Stimulation as a Novel Therapeutic Approach in Amyotrophic Lateral Sclerosis Status UNKNOWN Phase PHASE2
NCT01565395 Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) Status WITHDRAWN Phase PHASE2
NCT01551940 Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea Status COMPLETED Phase PHASE2
NCT01530438 Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis Status UNKNOWN Phase NA
NCT01521728 Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase NA
NCT01511029 Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate) Status COMPLETED Phase PHASE1
NCT01508962 PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01504009 Muscle Training of Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase NA
NCT01495390 A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers Status COMPLETED Phase N/A
NCT01494480 The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Status UNKNOWN Phase PHASE2
NCT01486849 Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT01459302 Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders Status WITHDRAWN Phase N/A
NCT01384162 An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis Status TERMINATED Phase PHASE1/PHASE2